• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肝脏精氨酸酶在大肠杆菌中的表达。产物的纯化及性质

Expression of human liver arginase in Escherichia coli. Purification and properties of the product.

作者信息

Ikemoto M, Tabata M, Miyake T, Kono T, Mori M, Totani M, Murachi T

机构信息

College of Medical Technology, Kyoto University, Japan.

出版信息

Biochem J. 1990 Sep 15;270(3):697-703. doi: 10.1042/bj2700697.

DOI:10.1042/bj2700697
PMID:2241902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1131788/
Abstract

Arginase is an enzyme that catalyses the hydrolysis of arginine to urea and ornithine. It is abundantly present in the liver of ureotelic animals (i.e. those whose excretion is characterized by the excretion of uric acid as the chief end-product of nitrogen metabolism), but its purification has hitherto not been simple, and the yield not high. Starting with a partially truncated cDNA for human liver arginase recently made available, we constructed an expression plasmid that had tandemly linked tac promotors placed upstream of a full-length cDNA. By selecting Escherichia coli strain KY1436 as the host micro-organism, we established an efficient system for the production of human liver arginase protein. Chromatographies on CM-Sephadex G-150, DEAE-cellulose and Sephadex G-150, followed by preparative agar-gel electrophoresis, yielded 10 mg of apparently homogeneous enzyme protein from 1 g (wet wt.) of E. coli cells. E. coli-expressed human liver arginase had chemical, immunological and most catalytic properties indistinguishable from those of purified human erythrocyte arginase. However, E. coli-expressed arginase was a monomer of Mr 35,000, whereas the purified erythrocyte arginase was trimer of Mr 105,000. They differed also in pH- and temperature-stabilities. Gel-filtration experiments with these two purified arginases under various conditions, as well as with unfractionated human liver and erythrocyte cytosol preparations, indicated that the native form of human arginase should be of Mr 35,000, and that the trimeric appearance of human erythrocyte arginase after purification was an artifact of the purification procedures. It was thus concluded that, in Nature, the liver and erythrocyte arginases are identical proteins.

摘要

精氨酸酶是一种催化精氨酸水解生成尿素和鸟氨酸的酶。它大量存在于排尿素动物的肝脏中(即那些以尿酸作为氮代谢主要终产物进行排泄的动物),但其纯化过程迄今并不简单,产量也不高。从最近获得的人肝脏精氨酸酶的部分截短cDNA开始,我们构建了一个表达质粒,该质粒在全长cDNA的上游串联连接了tac启动子。通过选择大肠杆菌菌株KY1436作为宿主微生物,我们建立了一个高效生产人肝脏精氨酸酶蛋白的系统。在CM - Sephadex G - 150、DEAE - 纤维素和Sephadex G - 150上进行层析,随后进行制备性琼脂凝胶电泳,从1克(湿重)大肠杆菌细胞中获得了10毫克明显均一的酶蛋白。大肠杆菌表达的人肝脏精氨酸酶在化学、免疫和大多数催化特性上与纯化的人红细胞精氨酸酶无法区分。然而,大肠杆菌表达的精氨酸酶是分子量为35,000的单体,而纯化的红细胞精氨酸酶是分子量为105,000的三聚体。它们在pH稳定性和温度稳定性方面也有所不同。在各种条件下对这两种纯化的精氨酸酶以及未分级的人肝脏和红细胞胞质溶胶制剂进行凝胶过滤实验表明,人精氨酸酶的天然形式应为分子量35,000,纯化后人红细胞精氨酸酶的三聚体形态是纯化过程造成的假象。因此得出结论,在自然界中,肝脏和红细胞精氨酸酶是相同的蛋白质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/721b/1131788/b8c1ac1fdbeb/biochemj00175-0139-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/721b/1131788/15d7fe9423f2/biochemj00175-0137-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/721b/1131788/b8c1ac1fdbeb/biochemj00175-0139-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/721b/1131788/15d7fe9423f2/biochemj00175-0137-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/721b/1131788/b8c1ac1fdbeb/biochemj00175-0139-a.jpg

相似文献

1
Expression of human liver arginase in Escherichia coli. Purification and properties of the product.人肝脏精氨酸酶在大肠杆菌中的表达。产物的纯化及性质
Biochem J. 1990 Sep 15;270(3):697-703. doi: 10.1042/bj2700697.
2
Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily.幽门螺杆菌精氨酸酶RocF的纯化与特性:精氨酸酶超家族中的独特特征
Eur J Biochem. 2004 May;271(10):1952-62. doi: 10.1111/j.1432-1033.2004.04105.x.
3
Expression, purification, and characterization of human type II arginase.人II型精氨酸酶的表达、纯化及特性分析
Arch Biochem Biophys. 2001 May 1;389(1):135-43. doi: 10.1006/abbi.2001.2324.
4
Purification and properties of human erythrocyte arginase.人红细胞精氨酸酶的纯化及性质
Ann Clin Biochem. 1989 Nov;26 ( Pt 6):547-53. doi: 10.1177/000456328902600616.
5
Cloning, expression, and characterization of a thermostable l-arginase from Geobacillus thermodenitrificans NG80-2 for l-ornithine production.嗜热栖热放线菌NG80-2中用于生产L-鸟氨酸的热稳定L-精氨酸酶的克隆、表达及特性分析
Biotechnol Appl Biochem. 2016 May;63(3):391-7. doi: 10.1002/bab.1385. Epub 2015 Jun 24.
6
Purification and properties of arginase from human liver and erythrocytes.人肝脏和红细胞中精氨酸酶的纯化及性质
Biochem J. 1978 Nov 1;175(2):449-54. doi: 10.1042/bj1750449.
7
Arginase of Bacillus brevis Nagano: purification, properties, and implication in gramicidin S biosynthesis.短芽孢杆菌长野亚种的精氨酸酶:纯化、性质及其在短杆菌肽S生物合成中的作用
Arch Biochem Biophys. 1997 Aug 1;344(1):37-42. doi: 10.1006/abbi.1997.0174.
8
Unique properties of arginase purified from camel liver cytosol.从骆驼肝胞质中纯化的精氨酸酶的独特性质。
Int J Biol Macromol. 2018 Mar;108:88-97. doi: 10.1016/j.ijbiomac.2017.11.141. Epub 2017 Nov 24.
9
Purification and kinetic properties of Mus booduga (Gray) hepatic arginase.印度沼鹿肝脏精氨酸酶的纯化及动力学特性
J Enzyme Inhib. 1997 Dec;12(4):255-72. doi: 10.3109/14756369709035818.
10
Purification and properties of liver arginase from teleostean fish Clarias batrachus (L.).来自鲶鱼(Clarias batrachus (L.))的肝脏精氨酸酶的纯化及性质
Arch Int Physiol Biochim. 1990 Dec;98(6):411-9. doi: 10.3109/13813459009114003.

引用本文的文献

1
Development and characterization of fused human arginase I for cancer therapy.融合人精氨酸酶 I 的构建及其在癌症治疗中的特性研究。
Invest New Drugs. 2023 Oct;41(5):652-663. doi: 10.1007/s10637-023-01387-y. Epub 2023 Aug 3.
2
Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2.虚拟筛选选择性抑制精氨酸酶 1 型和 2 型的 FDA 批准药物。
Molecules. 2022 Aug 12;27(16):5134. doi: 10.3390/molecules27165134.
3
arginase: biochemical characterization and inhibition by naturally occurring phenolic substances.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Modified reagents for determination of urea and ammonia.用于测定尿素和氨的改良试剂。
Clin Chem. 1962 Apr;8:130-2.
3
Liver arginase. III. Properties of highly purified arginase.肝脏精氨酸酶。III. 高纯度精氨酸酶的特性。
精氨酸酶:生化特性及天然酚类物质的抑制作用。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1100-1109. doi: 10.1080/14756366.2019.1616182.
4
Homoarginine and inhibition of human arginase activity: kinetic characterization and biological relevance.精氨酸同型物和人精氨酸酶活性的抑制作用:动力学特征和生物学相关性。
Sci Rep. 2018 Feb 27;8(1):3697. doi: 10.1038/s41598-018-22099-x.
5
High-level expression of human arginase I in Pichia pastoris and its immobilization on chitosan to produce L-ornithine.人精氨酸酶I在毕赤酵母中的高效表达及其固定于壳聚糖上用于生产L-鸟氨酸
BMC Biotechnol. 2015 Jul 31;15:66. doi: 10.1186/s12896-015-0184-2.
6
Increase in Red Blood Cell-Nitric Oxide Synthase Dependent Nitric Oxide Production during Red Blood Cell Aging in Health and Disease: A Study on Age Dependent Changes of Rheologic and Enzymatic Properties in Red Blood Cells.健康与疾病状态下红细胞衰老过程中依赖一氧化氮合酶的红细胞一氧化氮生成增加:红细胞流变学和酶学特性的年龄依赖性变化研究
PLoS One. 2015 Apr 22;10(4):e0125206. doi: 10.1371/journal.pone.0125206. eCollection 2015.
7
Expression, purification and characterization of arginase from Helicobacter pylori in its apo form.在 apo 形式下表达、纯化和鉴定幽门螺杆菌中的精氨酸酶。
PLoS One. 2011;6(10):e26205. doi: 10.1371/journal.pone.0026205. Epub 2011 Oct 20.
8
Crystallization of an apo form of human arginase: using all the tools in the toolbox simultaneously.人精氨酸酶脱辅基形式的结晶:同时运用工具箱中的所有工具。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Jan 1;67(Pt 1):90-3. doi: 10.1107/S1744309110046208. Epub 2010 Dec 23.
9
Inhibition of human arginase I by substrate and product analogues.人精氨酸酶 I 的底物和产物类似物的抑制作用。
Arch Biochem Biophys. 2010 Apr 15;496(2):101-8. doi: 10.1016/j.abb.2010.02.004. Epub 2010 Feb 12.
10
Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC).用于癌症治疗中体内持续活性的重组人精氨酸酶(rhArg1)聚乙二醇化衍生物:其体内外药效学的制备、表征及分析以及对肝癌细胞(HCC)的作用
Cancer Cell Int. 2009 Apr 17;9:9. doi: 10.1186/1475-2867-9-9.
Arch Biochem Biophys. 1956 Jun;62(2):446-53. doi: 10.1016/0003-9861(56)90143-6.
4
Immunologic studies of arginase in tissues of normal human adult and arginase-deficient patients.正常成年人体内组织中精氨酸酶及精氨酸酶缺乏症患者的免疫学研究。
Pediatr Res. 1983 Dec;17(12):941-4. doi: 10.1203/00006450-198312000-00003.
5
Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining.用于酶免疫测定和免疫组织化学染色的抗体及其片段的酶标记
J Immunoassay. 1983;4(3):209-327. doi: 10.1080/15321818308057011.
6
Plasmid vectors for the selection of promoters.用于启动子选择的质粒载体。
Gene. 1984 Feb;27(2):151-60. doi: 10.1016/0378-1119(84)90136-7.
7
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.pUC质粒,一种源自M13mp7的用于插入诱变和使用合成通用引物进行测序的系统。
Gene. 1982 Oct;19(3):259-68. doi: 10.1016/0378-1119(82)90015-4.
8
Molecular forms of human-liver arginase.人肝脏精氨酸酶的分子形式
Biochim Biophys Acta. 1966 Oct 17;128(1):149-54. doi: 10.1016/0926-6593(66)90151-2.
9
Molecular characteristics of rat liver arginase.大鼠肝脏精氨酸酶的分子特征
J Biol Chem. 1968 Dec 10;243(23):6123-9.
10
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.